Patient Preference

A study of patients who received dialysis at centers across the United States revealed no link between neighborhood food environment – including access to “healthy foods” and socioeconomic status – and hyperphosphatemia.

A speaker at the virtual Innovations in Dialysis: Expediting Advances Symposium discussed how patient-preference information can be used by the FDA in making regulatory decisions on devices designed for patients with kidney failure.

Many pregnant women refrain from asking questions during maternal care visits, according to research published in JAMA Network Open.

Many physicians treating older patients who require surrogate decision-makers experience moral distress, according to research recently published in the Journal of General Internal Medicine.

When the American Society of Nephrology’s Kidney Health Initiative was established in 2012, there was a greater need for innovative techniques and treatments among the kidney community. Since that time, the program has built upon its mission of advancing scientific understanding of kidney health and patient safety implications for new and current medical products and fostering the development of new therapies.

The FDA has awarded a contract to the Kidney Health Initiative for a 3-year project that aims to measure patient preferences and risk tolerance for the creation of novel, renal replacement therapy devices. According to a press release, the project responds to Advancing American Kidney Health, which calls for surveys gauging patient preferences for kidney failure treatments.